A commentary on the new ESC guidelines on dyslipidaemias

Heinz Drexel^{1

2

3}

Affiliations

¹ Vorarlberg Institute for Vascular Investigation and Treatment (VIVIT), Academic Teaching Hospital Feldkirch, Carinagasse 47, Feldkirch, A-6800 Austria.
² Private University of the Principality of Liechtenstein, Dorfstrasse 24, Triesen, FL-9495 Liechtenstein.
³ Drexel University, College of Medicine, Philadelphia, PA, USA.

Editorial

Heinz Drexel. Eur Heart J Cardiovasc Pharmacother. 2017.

. 2017 Apr 1;3(2):73-74.

doi: 10.1093/ehjcvp/pvx001.

Heinz Drexel^{1

2

3}

¹ Vorarlberg Institute for Vascular Investigation and Treatment (VIVIT), Academic Teaching Hospital Feldkirch, Carinagasse 47, Feldkirch, A-6800 Austria.
² Private University of the Principality of Liechtenstein, Dorfstrasse 24, Triesen, FL-9495 Liechtenstein.
³ Drexel University, College of Medicine, Philadelphia, PA, USA.

No abstract available

Comment on

2016 ESC/EAS Guidelines for the Management of Dyslipidaemias.
Catapano AL, Graham I, De Backer G, Wiklund O, Chapman MJ, Drexel H, Hoes AW, Jennings CS, Landmesser U, Pedersen TR, Reiner Ž, Riccardi G, Taskinen MR, Tokgozoglu L, Verschuren WMM, Vlachopoulos C, Wood DA, Zamorano JL, Cooney MT; ESC Scientific Document Group. Catapano AL, et al. Eur Heart J. 2016 Oct 14;37(39):2999-3058. doi: 10.1093/eurheartj/ehw272. Epub 2016 Aug 27. Eur Heart J. 2016. PMID: 27567407 No abstract available.